Annual Meeting
Date
June 24, 2026
Time
9:00 AM ET
Virtual Meeting
Note: You must register to be eligible to participate in the meeting.
Please vote your proxy online now using the following link, or by telephone
at 866-307-4662.
Date
June 24, 2026
Time
9:00 AM ET
Virtual Meeting
Note: You must register to be eligible to participate in the meeting.
Foghorn is a clinical stage, precision therapeutics biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system, an untapped opportunity for therapeutic intervention in oncology and with potential in a wide spectrum of other diseases, including immunology and inflammation.
Using our Gene Traffic Control® proprietary platform, we are currently advancing more than seven programs, with one clinical-stage drug candidate currently in Phase 1 development.